Independent Panel to Advise Against Low-Dose Aspirin Regimen to Prevent Heart Attacks

October 12, 2021 by Dan McCue
Independent Panel to Advise Against Low-Dose Aspirin Regimen to Prevent Heart Attacks
An arrangement of aspirin pills. (AP Photo/Patrick Sison)

WASHINGTON — The longstanding recommendation that older individuals start taking a low-dose aspirin to stave off a potential first heart attack or stroke was wrong, according to draft guidelines released Tuesday by the U.S. Preventive Services Task Force 

The proposal from the task force, an independent, volunteer panel of national experts in disease prevention and evidence-based medicine, is based on its finding that the risk of serious side effects, like bleeding in the stomach, intestines, and brain, far outweighs the potential benefits.

Heart disease and stroke continue to be leading causes of mortality in the United States, accounting for about one in three deaths, the Task Force said.

“While daily aspirin use has been shown to lower the chance of having a first heart attack or stroke … the chance of bleeding increases with age and can be life-threatening,” the panel said.

“Based on new evidence … it is now recommended that once people turn 60 years old,  they should not consider starting to take aspirin because the risk of bleeding cancels out the benefits of preventing heart disease,” it said.

This recommendation only applies to people who are at higher risk for cardiovascular disease, have no history of it, and are not already taking daily aspirin.

When deciding whether patients should start taking aspirin to prevent a first heart attack or stroke, the panel recommends that clinicians consider age, heart disease risk, and bleeding risk. 

If an individual is already taking aspirin and has any questions, the task force recommends they talk to their clinician about their individual circumstances.

“The latest evidence is clear: starting a daily aspirin regimen in people who are 60 or older to prevent a first heart attack or stroke is not recommended,” said Dr. Chien-Wen Tseng, a task force member, in a written statement. “However, this task force recommendation is not for people already taking aspirin for a previous heart attack or stroke; they should continue to do so unless told otherwise by their clinician.”

The findings are a little different when it comes to people aged 40 to 59 who have been deemed to be at a higher risk of cardiovascular diseases.

“The latest information … shows a closer balance of benefits and harms than previously understood for people in their 50s and that starting aspirin use as young as 40 years old may have some benefit.”

Dr. John Wong, a member of the task force, said in a written statement said in light of the panel’s new findings, “It’s important that people who are 40 to 59 years old and don’t have a history of heart disease have a conversation with their clinician to decide together if starting to take aspirin is right for them.”

A+
a-
  • aspirin
  • heart attacks
  • strokes
  • US PReventive Services Task FOrce
  • In The News

    Health

    Voting

    Health

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    March 26, 2024
    by Dan McCue
    Consumers Warned to Avoid Certain Topical Pain Relief Products 

    WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed... Read More

    WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed for topical use before, during or after certain cosmetic procedures. The warning came after the agency issued warning letters to six companies for marketing these products... Read More

    News From The Well
    scroll top